Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm Pharmaceutical Investing
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 Medical Device Investing
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority Medical Device Investing
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes Biotech Investing
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting Biotech Investing
Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa Biotech Investing
Journey Medical Corporation to Participate in September 2025 Investor Conferences Pharmaceutical Investing
